Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations

Cancer Letters

Volumn 257, Issue 2, 2007, Pages 236-243

  Maor, Sharon ^a   Yosepovich, Ady ^b   Papa, Moshe Z ^b   Yarden, Ronit I ^b   Mayer, Doris ^c   Friedman, Eitan ^d   Werner, Haim ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

Author keywords

BRCA1; Breast cancer; IGF I receptor; Insulin like growth factor I (IGF I); Sp1

Indexed keywords

ADENOVIRUS VECTOR; BRCA1 PROTEIN; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR SP1;

ARTICLE; BREAST TUMOR; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING;

BINDING SITES; BLOTTING, WESTERN; BRCA1 PROTEIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECEPTOR, IGF TYPE 1; SP1 TRANSCRIPTION FACTOR; TIME FACTORS; TRANSFECTION;

EID: 35148841175     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.07.019     Document Type: Article

References (48)

1. Surmacz E. Function of the IGF-I receptor in breast cancer. J. Mammary Gland Biol. Neoplasia 5 (2000) 95-105
2. Yee D., and Lee A.V. Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J. Mammary Gland Biol. Neoplasia 5 (2000) 107-115
3. Werner H., and LeRoith D. The role of the insulin-like growth factor system in human cancer. Adv. Cancer Res. 68 (1996) 183-223
4. LeRoith D., Werner H., Beitner-Johnson D., and Roberts Jr. C.T. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrine Rev. 16 (1995) 143-163
5. Baserga R. The IGF-I receptor in cancer research. Exp. Cell Res. 253 (1999) 1-6
6. Sell C., Rubini M., Rubin R., Liu J.-P., Efstratiadis A., and Baserga R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc. Natl. Acad. Sci. USA 90 (1993) 11217-11221
7. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266 (1994) 66-71
8. Castilla L.H., Couch F.J., Erdos M.R., Hoskins K.F., Calzone K., Garber J.E., et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat. Genet. 8 (1994) 387-391
9. Futreal P.A., Liu Q., Shattuck-Eidens D., Cochran C., Harshman K., Tavtigian S., et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266 (1994) 120-122
10. Szabo C.I., and King M.C. Population genetics of BRCA1 and BRCA2. Am. J. Hum. Genet. 60 (1997) 1013-1020
11. Shiri-Sverdlov S.R., Oefner P., Green L., Baruch R.G., Wagner T., Kruglikova A., et al. Mutational analysis of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer. Hum. Mutat. 16 (2000) 491-501
12. Struewing J.P., Tarone R.E., Brody L.C., Li F.P., and Boice Jr. J.D. BRCA1 mutations in young women with breast cancer. Lancet 347 (1996) 1493
13. Abeliovich D., Kaduri L., Lerer I., Weinberg N., Amir G., Sagi M., et al. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am. J. Hum. Genet. 60 (1997) 505-514
14. Hartge P., Struewing J.P., Wacholder S., Brody L.C., and Tucker M.A. The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am. J. Hum. Genet. 64 (1999) 963-970
15. Wang Q., Zhang H., Fishel R., and Greene M.I. BRCA1 and cell signaling. Oncogene 19 (2000) 6152-6158
16. Kerr P., and Ashworth A. New complexities for BRCA1 and BRCA2. Curr. Biol. 11 (2001) R668-R676
17. Narod S.A., and Foulkes W.D. BRCA1 and BRCA2: 1994 and beyond. Nat. Rev. Cancer 4 (2004) 665-676
18. Chapman M.S., and Verma I.M. Transcriptional activation by BRCA1. Nature 382 (1996) 678-679
19. Monteiro A.N.A., August A., and Hanafusa H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. USA 93 (1996) 13595-13599
20. Scully R., Anderson S.F., Chao D.M., Wei W., Ye L., Young R.A., et al. BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Natl. Acad. Sci. USA 94 (1997) 5605-5610
21. Schlegel B.P., Green V.J., Ladias J.A., and Parvin J.D. BRCA1 interaction with RNA polymerase II reveals a role for hRPB2 and hRPB10α in activated transcription. Proc. Natl. Acad. Sci. USA 97 (2000) 3148-3153
22. Anderson S.F., Schlegel B.P., Nakajima T., Wolpin E.S., and Parvin J.D. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat. Genet. 19 (1998) 254-256
23. Yang X., and Lippman M.E. BRCA1 and BRCA2 in breast cancer. Breast Cancer Res. Treat. 54 (1999) 1-10
24. Holt J.T., Thompson M.E., Szabo C., Robinson-Benion C., Arteaga C.L., King M.C., et al. Growth retardation and tumour inhibition by BRCA1. Nat. Genet. 12 (1996) 298-301
25. Maor S.B., Abramovitch S., Erdos M.R., Brody L.C., and Werner H. BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Sp1. Mol. Genet. Metab. 69 (2000) 130-136
26. Abramovitch S., Glaser T., Ouchi T., and Werner H. BRCA1-Sp1 interactions in transcriptional regulation of the IGF-IR gene. FEBS Lett. 541 (2003) 149-154
27. Rohlfs E.M., Learning W.G., Friedman K.J., Couch F.J., Weber B.L., and Silverman L.M. Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis. Clin. Chem. 43 (1997) 24-29
28. Shiri-Sverdlov R., Gershoni-Baruch R., Ichezkel-Hirsch G., Gotlieb W.H., Bruchim Bar-Sade R., Chetrit A., et al. The Tyr978X BRCA1 mutation in non-Askenazi jews: occurrence in high-risk families, general population and unselected ovarian cancer patients. Community Genet. 4 (2001) 50-55
29. Liao Y., Abel U., Grobholz R., Hermani A., Trojan L., Angel P., et al. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade. Hum. Pathol. 36 (2005) 1186-1196
30. Yarden R.I., Pardo-Reoyo S., Sgagias M., Cowan K.H., and Brody L.C. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat. Genet. 30 (2002) 285-289
31. Idelman G., Glaser T., Roberts Jr. C.T., and Werner H. WT1-p53 interactions in IGF-I receptor gene regulation. J. Biol. Chem. 278 (2003) 3474-3482
32. Cooke D.W., Bankert L.A., Roberts Jr. C.T., LeRoith D., and Casella S.J. Analysis of the human type I insulin-like growth factor receptor promoter region. Biochem. Biophys. Res. Commun. 177 (1991) 1113-1120
33. Beitner-Johnson D., Werner H., Roberts Jr. C.T., and LeRoith D. Regulation of insulin-like growth factor I receptor gene expression by Sp1: physical and functional interactions of Sp1 at GC boxes and at a CT element. Mol. Endocrinol. 9 (1995) 1147-1156
34. Schnarr B., Strunz K., Ohsam J., Benner A., Wacker J., and Mayer D. Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer. Int. J. Cancer 89 (2000) 506-513
35. Werner H., Bach M.A., Stannard B., Roberts Jr. C.T., and LeRoith D. Structural and functional analysis of the insulin-like growth factor I receptor gene promoter. Mol. Endocrinol. 6 (1992) 1545-1558
36. Dunn S.E., Hardman R.A., Kari F.W., and Barrett J.C. Insulin-like growth factor I alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res. 57 (1997) 2687-2693
37. Happerfield L.C., Miles D.W., Barnes D.M., Thomsen L.L., Smith P., and Hanby A.M. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue. J. Pathol. 183 (1997) 412-417
38. Peyrat J.P., and Bonneterre J. Type 1 IGF receptor in human breast diseases. Breast Cancer Res. Treat. 22 (1992) 59-67
39. Lee A.V., Hilsenbeck S.G., and Yee D. IGF system components as prognostic markers in breast cancer. Breast Cancer Res. Treat. 47 (1998) 295-302
40. Lee A.V., Jackson J.G., Gooch J.L., Hilsenbeck S.G., Coronado-Heinsohn E., Osborne C.K., et al. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol. Endocrinol. 13 (1999) 787-796
41. Turner B.C., Haffty B.G., Narayanan L., Yuan J., Havre P.A., Gumbs A.A., et al. Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res. 57 (1997) 3079-3083
42. Papa V., Gliozzo B., Clark G.M., McGuire W.L., Moore D., Fujita-Yamaguchi Y., et al. Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res. 53 (1993) 3736-3740
43. Yee D. The insulin-like growth factor system as a target in breast cancer. Breast Cancer Res. Treat. 32 (1994) 85-95
44. Cable P.L., Wilson C.A., Calzone F.J., Rauscher F.J.I., Scully R., Livingston D.M., et al. Novel consensus DNA-binding sequence for BRCA1 protein complexes. Mol. Carcinog. 38 (2003) 85-96
45. Voskuil D.W., Bosma A., Vrieling A., Rookus M.A., and van't Veer L.J. Insulin-like growth factor system mRNA quantities in normal and tumor breast tissue of women with sporadic and familial breast cancer risk. Breast Cancer Res. Treat. 84 (2004) 225-233
46. Loman N., Johansson O., Bendahl P.-O., Borg A., Ferno M., and Olsson H. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer 83 (1998) 310-319
47. Osin P.P., and Lakhani S.R. The pathology of familial breast cancer. Immunohistochemistry and molecular analysis. Breast Cancer Res. 1 (1999) 36-40
48. Eerola H., Heikkila P., Tamminen A., Aittomaki K., Blomqvist C., and Nevanlinna H. Relationship of patient's age to histopathological features of breast tumors in BRCA1 and BRCA2 and mutation-negative breast cancer families. Breast Cancer Res. 7 (2005) R465-R469